CompletedPhase 4

Rate Control in Atrial Fibrillation

Iran90 participantsStarted 2011-02

Plain-language summary

Rate control in atrial fibrillation is a usual battle in emergency departments. Oral medications have a natural superiority to intravenous ones because they are easy-to-use and decrease the workload in busy emergency departments. This study wants to find an effective oral medication for rate control in rapid ventricular response atrial fibrillation. Propranolol and Metoprolol, Diltiazem and Verapamil are compared in patients with a stable hemodynamic status.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age more than 18 years old * Stability in hemodynamic Exclusion Criteria: * Systolic blood pressure less than 90 mm Hg * Altered mental status attributable to rapid ventricular response atrial fibrillation * Acute pulmonary edema attributable to rapid ventricular response atrial fibrillation * Chest pain attributable to rapid ventricular response atrial fibrillation * Allergy to Propranolol or Metoprolol or Verapamil or Diltiazem * History of asthma

What they're measuring

Rate less than 100 per minute

Timeframe: In 1 hour

Trial details

NCT IDNCT01655303

SponsorTehran University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

View on ClinicalTrials.gov More Rapid Ventricular Response Atrial Fibrillation trials